Jennifer Kang is Head of Portfolio & Strategy Management at Formation Bio. She has attended the World Vaccine Congress and contributed to a paper on PK assay strategies for antibody-drug conjugate development. She holds a degree from the University of Notre Dame and is based in the New York City metropolitan area.
666 3rd Ave, 6th Floor, New York, NY 10017